Lertsakulbunlue, Sethapong
Kantiwong, Anupong
Article History
Received: 1 March 2024
Accepted: 28 January 2025
First Online: 18 February 2025
Declarations
:
: The study received approval by the Medical Department Ethics Review Committee for Research in Human Subjects, Institutional Review Board, Royal Thai Army (IRBRTA) (Approval no. S086h/66_Xmp), following international guidelines such as the Declaration of Helsinki, the Belmont Report, CIOMS Guidelines, and the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use—Good Clinical Practice. The IRBRTA waived the requirement for participant informed consent, deeming it unnecessary in accordance with national regulations.
: Not applicable.
: The authors declare no competing interests.